Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo

Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo

Thumbnail Image
Download
Name

Novoa-2014-Analogs of natural a.pdf

Size

1.44 MB

Format

Adobe PDF

Checksum (MD5)

88833a222e18583f5f4aef8c399ba0b0

Author(s)
Camacho, Noelia
•
Tor, Anna
•
Wilkinson, Barrie
•
Moss, Steven
•
Mirando, Adam C.
•
Francklyn, Christopher S.
•
Royo, Miriam
•
Novoa Pardo, Eva Maria
•
Marin-Garcia, Patricia
•
Axcarate, Isabel G.
more
Date Issued
December 2014
Journal
Proceedings of the National Academy of Sciences
Publisher
National Academy of Sciences (U.S.)
Citation
Novoa, Eva Maria, Noelia Camacho, Anna Tor, Barrie Wilkinson, Steven Moss, Patricia Marin-Garcia, Isabel G. Azcarate, et al. “Analogs of Natural Aminoacyl-tRNA Synthetase Inhibitors Clear Malaria in Vivo.” Proceedings of the National Academy of Sciences 111, no. 51 (December 8, 2014): E5508–E5517.
Version
Final published version
Abstract
Malaria remains a major global health problem. Emerging resistance to existing antimalarial drugs drives the search for new antimalarials, and protein translation is a promising pathway to target. Here we explore the potential of the aminoacyl-tRNA synthetase (ARS) family as a source of antimalarial drug targets. First, a battery of known and novel ARS inhibitors was tested against Plasmodium falciparum cultures, and their activities were compared. Borrelidin, a natural inhibitor of threonyl-tRNA synthetase (ThrRS), stands out for its potent antimalarial effect. However, it also inhibits human ThrRS and is highly toxic to human cells. To circumvent this problem, we tested a library of bioengineered and semisynthetic borrelidin analogs for their antimalarial activity and toxicity. We found that some analogs effectively lose their toxicity against human cells while retaining a potent antiparasitic activity both in vitro and in vivo and cleared malaria from Plasmodium yoelii-infected mice, resulting in 100% mice survival rates. Our work identifies borrelidin analogs as potent, selective, and unexplored scaffolds that efficiently clear malaria both in vitro and in vivo.
MIT Department
Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
http://hdl.handle.net/1721.1/97421
DOI of Published Version
https://doi.org/10.1073/pnas.1405994111
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.